Investigation Report on China Latanoprost Market[2010-2019]

Investigation Report on China Latanoprost Market[2010-2019]

Bharat Book Bureau provides the report, on “Investigation Report on China Latanoprost Market [2010-2019] ” The report provides a basic overview of The 2015 Worldwide Electronic Computer Manufacturing Industry-Industry & Market Report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. https://www.bharatbook.com/drugs-market-research-reports-697097/investigation-china-latanoprost.html

21st Dec 2015- Mumbai, India: Bharatbook.com announces a report on “Investigation Report on China Latanoprost Market [2010-2019] ” The report also includes industry definition, 5-year historical trends on industry sales, establishments and employment and estimates on up to 10 sub-industries, mainframe manufacturing, personal computer manufacturing and minicomputers manufacturing.

Glaucoma is an irreversible eye disorder which can lead to blindness. According to the statistics published by WHO in 2005, glaucoma is the second-leading cause of blindness after cataract. The number of glaucoma patients around the world is 70 million and will reach 80 million by 2020. And 50% of blindness cases in the world are caused by glaucoma. According to epidemiological studies of eye disease, by Feb. 2015, 2.3% of people aged above 40 suffer from glaucoma, among which about 30% may become blind. And it is predicted that by 2020, there will be about 21 million glaucoma patients in China.

Developed by Pharmacia & Upjohn in 1995, latanoprost is a selective prostaglandin receptor agonist which effectively reduces intraocular pressure. As the first pressure-lowering prostaglandin approved by FDA, latanoprost (under the trade name of Xalatan) entered China in 1999. In 2004, latanoprost eye drop developed by Lunan Better Pharmaceutical Co., Ltd was approved to be marketed, followed by products of Merro Pharmaceutical Co., Ltd, Hengrui Pharmaceutical and China Resources Zizhu...